Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
U. Sester, H. Wilkens, U. Mack, G. W. Sybrecht, M. Sester (Homburg, Germany). Monitoring T-cell immunity towards M. tuberculosis: impaired specific immunocompetence in patients receiving high levels of immunosuppressive drugs. Eur Respir J 2008; 32: Suppl. 52, 4522

Member's Comments

Paul Kelly - 07.10.2008 10:10
P Kelly
That immunosupression - iatrogenic or due to disease - lowers the capability to react to TB is clear. Yo seem to argue that in vitro testing might be an alternative to skin testins but irrespective of which test is used what clinical impact does a positive result have ?

Massimo Amicosante - 04.10.2008 09:52
Bio-equivalent of calcineurin inhibitors concentration
very nice and extensive work. For providing a further indication to clinically oriented audience, could you please add information about the in vivo bioequivalance of the calcineurin inhibitors used for the in vitro experiments? and not only present the data obtained ex vivo after peak injection of cyclosporin A.

Related content which might interest you: Impaired detection of Mycobacterium tuberculosis immunity in patients using high levels of immunosuppressive drugs Source: Eur Respir J 2009; 34: 702 Year: 2009 The status of populations of cell-mediated lung immunity effectors after chemotherapy of experimental MDR tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 656s Year: 2005 T-cell response against tuberculosis antigens is dependent on the level of immunosuppression in renal and lung transplant patients Source: Eur Respir J 2006; 28: Suppl. 50, 344s Year: 2006 Comparison of effector T-cell responses in patients with active TB disease compared to latent TB infection Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease Year: 2007 An influence of small doses of corticosteroids on immune defense in active pulmonary tuberculosis in humans Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009 Paradoxical reactions (PR) related to tuberculosis (TB) treatment are associated with increased antigen-specific T cell responses in the lung Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009 Does BCG revaccination lead to enhanced protective immunity against tuberculosis? A study using surrogate markers Source: Annual Congress 2005 - Epidemiology and control of tuberculosis and LTBI Year: 2005 Increasing immunosuppression despite high load of respiratory viruses: Fludarabine as rescue treatment in alloreactive lung disease Source: Annual Congress 2011 - Paediatric respiratory infection: signs, symptoms and sequelae Year: 2011 Role of adaptive immunity in clinical variability of active tuberculosis patients Source: Virtual Congress 2021 – Novel imaging analysis methodologies in diffuse lung diseases Year: 2021 Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to mycobacterium tuberculosis: a pilot study Source: Eur Respir J 2007; 30: Suppl. 51, 753s Year: 2007 Radiological findings of inactive tuberculosis do not correlate with M. tuberculosis-specific T-cell immunity in high-risk patients Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease Year: 2008 IFN-gamma response on T-cell based assays in HIV patients for detection of tuberculosis infection Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease Year: 2008 Influence of thyroid function activity on the indexis of immunity in tuberculosis patients Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017 Evaluation of tuberculosis risk in patients submitted to chronic immunosuppressive therapy for osteoarticular immune disease Source: Eur Respir J 2006; 28: Suppl. 50, 131s Year: 2006 Monitoring of ESAT-6/CFP-10 selected peptides response during prophylaxis in individuals exposed to M. tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 363s Year: 2006 Tuberculosis treatment effect on T-cell interferon-γ responses to Mycobacterium tuberculosis-specific antigens Source: Eur Respir J 2010; 36: 355 Year: 2010 Functional and memory status of M. tuberculosis specific T-cells in HIV-infected patients naïve to antiretroviral treatment Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection Year: 2014 Tuberculosis therapy: past, present and future Source: Eur Respir J 2002; 20: 87S-94S Year: 2002 Estimation immune and cytokine status of children infected M.tuberculosis Source: Annual Congress 2008 - Specific tuberculosis management problems in children and adolescents Year: 2008 Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011